FERRIPROX (ApoPharma USA, Inc.)
Welcome to the PulseAid listing for the FERRIPROX drug offered from ApoPharma USA, Inc.. This Iron Chelating Activity [MoA],Iron Chelator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | ApoPharma USA, Inc. |
NON-PROPRIETARY NAME: | deferiprone |
SUBSTANCE NAME: | DEFERIPRONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Iron Chelating Activity [MoA],Iron Chelator [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2011-11-25 |
END MARKETING DATE: | 0000-00-00 |
FERRIPROX HUMAN PRESCRIPTION DRUG Details:
Item Description | FERRIPROX from ApoPharma USA, Inc. |
LABELER NAME: | ApoPharma USA, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/1) |
START MARKETING DATE: | 2011-11-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52609-0006_abd64643-d7c2-4db0-bd2d-16f4350d8fa9 |
PRODUCT NDC: | 52609-0006 |
APPLICATION NUMBER: | NDA021825 |
Other DEFERIPRONE Pharmaceutical Manufacturers / Labelers: